The news desk

Peptide news

Research, regulatory, and market news in a neutral house voice, each story reviewed by a named editor and linked to the peptides it mentions.

Regulatory

FDA updates compounding guidance affecting GLP-1 availability

New agency guidance narrows when compounding pharmacies may prepare certain GLP-1 and related peptide products, with knock-on effects for supply.

Peptide.it editorial team · 2026-06-04 · 4 min read